Advertisement Neptune announces production facility expansion - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Neptune announces production facility expansion

Neptune Technologies and Bioressources, a manufacturer of phospholipid products for the pharmaceutical industry, has announced the commencement of its Phase I plant expansion at Sherbrooke, Québec.

The company hopes to generate an additional production capacity of more than 150,000kg per year within a year.

The expansion of facility will be executed in two phases, leading to production up to 500,000kg of Neptune Krill oil per year.

Neptune CFO André Godin said the expansion would enforce their manufacturing position and increase the supply of its products.

"This new production line will secure supply for the increasing demand, allowing for incremental gross margin, as well as providing additional production capacity for new products currently under development," Godin added.